Sexual health is rarely the first topic that comes up in an EDS clinic appointment. Between managing symptoms and the long list of comorbidities that can define life with hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD), sexual wellbeing can feel like a lower priority, or something too personal to raise with a healthcare provider. But for many people living with these conditions, sexual problems can be a real and significant part of their experience, and one that deserves clinical attention and honest conversation.
A new study from the Mayo Clinic’s EDS Clinic in Florida offers one of the most comprehensive overviews of sexual problems in patients with hEDS and HSD to date, examining both females and males across more than 1,400 patients.
About This Study
Researchers examined self-reported data from 1,407 adult patients at the Mayo Clinic Florida EDS Clinic between 2020 and 2025. Patients completed a validated screening questionnaire covering eight indicators of sexual problems, including sexual interest, sexual pain, orgasm difficulty, sexual anxiety, sexual pleasure, vaginal dryness for women, and erection difficulty for men. Results were compared between patients with hEDS, patients with HSD, and a control group of patients with chronic pain who did not have a hypermobility diagnosis. This control group is an important distinction, as using chronic pain controls rather than healthy controls means the findings are less likely to reflect chronic illness in general and more likely to reflect something specific to hypermobility.
Of the 1,407 patients, 69% were diagnosed with HSD, 17% with hEDS, and 14% were chronic pain controls. Consistent with the known sex imbalance in these conditions, approximately 90% of patients in each group were female.
What the Study Found: Females With hEDS
The most significant findings were in women with hEDS, who reported substantially higher rates of sexual problems than chronic pain controls across multiple categories.
Nearly 70% of women with hEDS reported sexual problems overall, compared with 57% of chronic pain controls, an already high baseline that underscores how common these issues can be in people living with chronic pain more broadly. But women with hEDS reported significantly more problems across specific categories: 41% reported problems with sexual interest, compared with 30% of controls; 45% reported sexual pain, compared with 31% of controls; and 34% reported difficulty with orgasm, compared with 23% of controls.
Sexual pain, known clinically as dyspareunia when it occurs during or after intercourse, is thought to be linked in part to the connective tissue dysfunction that defines hEDS. The pelvic region relies heavily on collagen and connective tissue for structural support. When that tissue is fragile or unstable, as it can be in hEDS, the consequences can include hip instability, pelvic floor dysfunction, and pain with sexual activity. The authors also note that previous physical trauma, infections, mast cell activation and autonomic dysfunction may further contribute to sexual problems in this population.
The study also examined genitourinary symptoms, or problems involving the bladder, urethra, and reproductive organs, to understand whether these might help explain the sexual problems reported by women with hEDS. Compared with men with hEDS, women with hEDS reported significantly higher rates of dyspareunia, or pain during intercourse (31.9% compared with 0% of men); recurrent urinary tract infections (37.1% compared with 6.7% of men); urinary incontinence, or involuntary leakage of urine (30% compared with 3.6% of men); pelvic floor dysfunction, a condition in which the muscles and connective tissue supporting the pelvic organs are weakened or impaired (26.7% compared with 3.3% of men); and recurrent yeast infections (22.9% compared with 0% of men). The authors suggest that these genitourinary issues may contribute directly to the sexual problems reported by women with hEDS.
What the Study Found: Males With hEDS
An equally important finding is what the study found for men. Males with hEDS did not report significantly more sexual problems than male chronic pain controls across any of the eight categories examined, including erection difficulty.
This is a meaningful result for several reasons. It suggests that the elevated sexual problem burden in hEDS is not simply a reflection of living with a chronic, painful condition. If it were, men would be expected to show similar patterns to women. Instead, the findings may point toward something more specific to the biology of hEDS in women, possibly related to the role of connective tissue in pelvic and genitourinary function, hormonal differences, or other sex-based factors that are not yet fully understood.
The authors are careful to note that the small number of men in the study limits how firm these conclusions can be, and that future research with larger male cohorts is needed. But for men with hEDS who have not experienced significant sexual problems, this finding may offer some reassurance, and for clinicians, it reinforces the importance of tailoring assessment and care to the individual patient rather than assuming all hEDS patients share the same profile.
What the Study Found: HSD
For patients with HSD, both male and female, the picture was different. The only sexual problem that was significantly more common in HSD patients compared to chronic pain controls was problems with sexual interest. Among women with HSD, 39.5% reported problems with sexual interest compared with 29.7% of female chronic pain controls. The difference was even more pronounced in men, with 33.3% of males with HSD reporting problems with sexual interest compared with only 7.7% of male chronic pain controls. This is a striking gap, though one that should be interpreted carefully given the small number of men in the study.
No other significant differences were found between HSD patients and chronic pain controls across any other sexual problem category.
Women with hEDS reported significantly higher rates of sexual problems across more categories than women with HSD when each group was compared with chronic pain controls. It is important to note, however, that when the hEDS and HSD groups were compared against each other, women with hEDS generally reported higher percentages, but these differences were not statistically significant. This means there was insufficient evidence to establish higher rates of sexual problems in hEDS than HSD. The authors suggest that connective tissue differences may help explain these findings. They note that hEDS diagnostic criteria include features such as stretchy skin, while previous research found more prolapses and dislocations in hEDS than HSD. They propose that weaker collagen and extracellular matrix integrity could make the pelvic region more vulnerable to dysfunction.
Why This Matters
The authors note that in the general population, approximately 12% of women experience sexual dysfunction related to desire, arousal, or orgasm, and 13–21% experience painful sex. The rates reported in women with hEDS in this study are substantially higher, and may even be an underestimate, since the control group used in this study already had chronic pain, which can itself impair sexual function.
Despite how common these problems appear to be, sexual health remains under-addressed in EDS care. The authors recommend that patients with relevant symptoms be considered for referral to gynecology, urology, and pelvic floor physical therapy, three specialties that can offer meaningful support for many of the issues identified in this study.
Key Takeaways
- Women with hEDS reported significantly higher rates of sexual problems than chronic pain controls, including sexual pain, problems with sexual interest, and orgasm difficulty.
- Nearly 70% of women with hEDS reported sexual problems overall, which is substantially higher than the rate in the general population.
- Genitourinary symptoms including dyspareunia, recurrent urinary tract infections, urinary incontinence, and pelvic floor dysfunction were significantly more common in women with hEDS than men with hEDS, and may contribute directly to sexual problems.
- Men with hEDS did not report significantly more sexual problems than male chronic pain controls, which may indicate sex-specific biological factors rather than chronic illness alone. Though future research with larger male cohorts is needed.
- For patients with HSD, the only sexual problem significantly elevated above controls was problems with sexual interest, for both men and women.
- Patients experiencing sexual problems should consider raising them with their care team, and referral to gynecology, urology, or pelvic floor physical therapy may be appropriate.
Final Thoughts
Sexual health is part of overall health, and for people living with hEDS, it is an area where the condition’s impact can be profound and persistent. Research like this helps bring these experiences into the clinical conversation.
If you are living with sexual problems related to your hEDS or HSD, there are specialists who can help. Raising these concerns with your healthcare provider is a reasonable and well-supported step, and one that research such as this can make easier to take.
By Jacqueline Moltzau Anderson, PhD
Researcher at University of California
November, 2026
A Note From Chronic Pain Partners: This article focuses on the findings of one study and does not cover every possible cause of sexual pain. Coexisting conditions, such as endometriosis and pelvic congestion syndrome, can also cause pelvic pain and may require specific evaluation and treatment. Pain during or after sex should not automatically be attributed to EDS or HSD. If you experience new, persistent, or recurring pain, discuss it with your healthcare provider rather than accepting it as an inevitable part of hypermobility.
If you like what you read, please comment and share!





